Generics Bulletin is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Sandoz International GmbH

Division of Novartis AG

Latest From Sandoz International GmbH

Stada Takes Lead In Russia's OTC Market As Group Sales Rise Double-Digits

Stada has taken the lead in the Russian OTC market and is implementing a turnaround plan in the country to take the business to the next level. 

Russian Federation Business Strategies

Testing Ranitidine With Too Much Heat Could Generate NDMA, FDA Says

FDA recommends using "Liquid Chromatography-High Resolution Mass Spectrometry Method" for testing ranitidine rather than method apparently used by online pharmacy Valisure, which asked agency to halt production and order recalls.

OTC Drugs Regulation

Apotex First In US To Recall OTC Ranitidine Tablets Due To NDMA Impurity

Apotex recalls 13 OTC ranitidine tablet products it provided to Walmart, Walgreens and Rite Aid. FDA has no information on plans by nine other firms that, like Apotex, have approved ANDAs for copies of Zantac 75- and 150-mg tablets, which also remain available.

OTC Drugs Drug Safety

Aurolife OTC Fexofenadine, Tween Brands Just Shine Cosmetics Among Recalls

Consumer health and cosmetic product recalls added to FDA database on 18 and 25 September also include lidocaine topicals Ridge Properties provides for use in OTC products marketed as pre-tattoo prep or for pain or itch relief after the products were found to be contaminated and above specification for lidocaine assay.

OTC Drugs Cosmetics
See All

Company Information